₹ 2.4 Cr
Volume transacted
7.8 K
stocks traded
Last Updated time: 25 Jul 9.00 AM
Hester Biosciences Ltd
NSE: HESTERBIO
PE
139.3
Last updated : 25 Jul 9.00 AM
The P/E Ratio of Hester Biosciences Ltd is 139.3 as of 25 Jul 9.00 AM .a1#The P/E Ratio of Hester Biosciences Ltd changed from 31.6 on March 2019 to 48.6 on March 2023 . This represents a CAGR of 8.99% over 5 years. a1#The Latest Trading Price of Hester Biosciences Ltd is ₹ 3092 as of 25 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.3 to 27.3 in 5 years. This represents a CAGR of -0.72%a1# The PE Ratio of Automobile industry is 18.9. The PE Ratio of Finance industry is 23.5. The PE Ratio of IT - Software industry is 29.1. The PE Ratio of Pharmaceuticals industry is 38.6. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 24.3. In 2024a1#The Market Cap of Hester Biosciences Ltd changed from ₹ 1314 crore on March 2019 to ₹ 1293 crore on March 2023 . This represents a CAGR of -0.32% over 5 years. a1#The Revenue of Hester Biosciences Ltd changed from ₹ 55.39 crore to ₹ 83.88 crore over 8 quarters. This represents a CAGR of 23.06% a1#The EBITDA of Hester Biosciences Ltd changed from ₹ 12.12 crore to ₹ 20.55 crore over 8 quarters. This represents a CAGR of 30.21% a1#The Net Pr of Hester Biosciences Ltd changed from ₹ 3.56 crore to ₹ 6.4 crore over 8 quarters. This represents a CAGR of 34.08% a1#The Dividend Payout of Hester Biosciences Ltd changed from 21.35 % on March 2019 to 21.05 % on March 2023 . This represents a CAGR of -0.28% over 5 years. a1#
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Period | |
---|---|
Mar '19 | 31.6 |
Mar '20 | 27 |
Mar '21 | 47.4 |
Mar '22 | 58.8 |
Mar '23 | 48.6 |
Market Cap
₹ 2,631 Cr
EPS
₹ 22.2
P/E Ratio (TTM) *
139.3
P/B Ratio (TTM) *
9.0
Day’s High
₹ 3214.0
Day’s Low
₹ 2668.55
DTE *
0.8
ROE *
6.5
52 Week High
₹ 3214.0
52 Week Low
₹ 1292.9
ROCE *
8.7
* All values are consolidated
Last Updated time: 25 Jul 9.00 AM
* All values are consolidated
Last Updated time: 25 Jul 9.00 AM
Hester Biosciences Ltd
NSE: HESTERBIO
PRICE
₹ 3092.8
373.55 (13.74%)
Last updated : 25 Jul 15:30
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
* All values are in Rupees
Strength
3
S
Weakness
1
W
Opportunity
0
O
Threats
1
T
Market Value
₹ 2,631
Asset Value
₹ 229
10.5 X
Value addition
* All values are in Rupees
Company Name | PE | Market Cap (INR Cr.) |
---|---|---|
Hester Biosciences Ltd | 139 | 2,631 |
Sun Pharmaceuticals Industries Ltd | 40 | 399,537 |
Zydus Lifesciences Ltd | 31 | 121,312 |
Cipla Ltd | 28 | 121,120 |
Divis Laboratories Ltd | 75 | 120,782 |
Dr Reddys Laboratories Ltd | 20 | 114,348 |
Earnings
₹18 Cr
139.3 X
PE Ratio
Market Cap
₹2631Cr
PE Ratio
PS Ratio
PB Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E ratio = (CMP of share/ Earning per share)
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Earnings
₹18 Cr
139.3 X
PE Ratio
Market Cap
₹2631Cr
PE Ratio
PS Ratio
PB Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E ratio = (CMP of share/ Earning per share)
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Period | |
---|---|
Mar '19 | 1315 |
Mar '20 | 787 |
Mar '21 | 1631 |
Mar '22 | 2310 |
Mar '23 | 1293 |
* All values are a in ₹crore
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Period | |
---|---|
Jun '22 | 55 |
Sep '22 | 78 |
Dec '22 | 81 |
Mar '23 | 71 |
Jun '23 | 90 |
Sep '23 | 76 |
Dec '23 | 69 |
Mar '24 | 84 |
* All values are a in ₹crore
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Period | |
---|---|
Jun '22 | 12 |
Sep '22 | 18 |
Dec '22 | 25 |
Mar '23 | 15 |
Jun '23 | 17 |
Sep '23 | 19 |
Dec '23 | 12 |
Mar '24 | 21 |
* All values are a in ₹crore
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Period | |
---|---|
Jun '22 | 4 |
Sep '22 | 7 |
Dec '22 | 12 |
Mar '23 | 6 |
Jun '23 | 7 |
Sep '23 | 4 |
Dec '23 | 4 |
Mar '24 | 6 |
* All values are a in ₹crore
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Period | |
---|---|
Mar '19 | 21 |
Mar '20 | 18 |
Mar '21 | 21 |
Mar '22 | 22 |
Mar '23 | 21 |
* All values are a in %
Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India. Since its incorporation in Apr' 87, the Company has been engaged in the production and distribution of vaccines and health products. Headquartered in Ahmedabad, Gujarat, the Company is currently the second-largest maker of poultry vaccines in India, having acquired strong brand equity over the years. The Company principally engages in two business verticals, namely Poultry Healthcare and Animal Healthcare. Its products are registered with several countries, and internal agencies, and have gained widespread recognition in both India and international markets. It has built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh. The products and services offered include over 51 vaccines and 70+ health products. In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals. The Company markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company received licenses for producing 10 additional poultry vaccines. It signed a manufacturing agreement with Sinsui Inc for producing poultry vaccines. In 2003, Hester was appointed as the exclusive Indian distributor by BIOPHARM of Czech Republic, for their coccidiosis vaccine - LIVACOX. Hester commenced business with Merial in the 3rd quarter of the financial year by importing poultry vaccines from them in 2004-05 and therefore, name of Company was changed from HESTER PHARMACEUTICALS LIMITED to HESTER BIOSCIENCES LIMITED. The Company embarked on an expansion program, to increase its capacity from 1200 million doses to 4800 million doses, which was commenced in January 2006. The expansion project and the new expanded capacity went on-stream in March 2007. The distribution network within India was made functional with company managed depots at Pune, Bangalore, Coimbatore, Hyderabad and Chandigarh, having state-of-art cold store facilities to maintain the cold chain. Distribution costs were further cut by embarking on the use of company owned refrigerated vans for deliveries all across India. In January 2010, the company re-launched the freeze dried MD Vaccine after 5 years. A JV was set-up in Nepal to facilitate manufacture of specific animal vaccines for international markets in 2011 for a project which costed Rs 15 crores. New technology was acquired. The Company signed a technology transfer agreement with Indian Veterinary Research Institute for acquiring technology to manufacture PPR and Sheep Pox vaccines in 2011. Company re-launched the bivalent Marek's Disease Live vaccine for the poultry, containing HVT & SB1 strains in 2012-13. It operationalised large animal vaccines division in Mar' 15. During the financial year 2014-15, Gujarat Agrofarm Limited became a wholly owned subsidiary of the Company. During financial year 2015-16, three wholly owned subsidiary Companies namely Gujarat Agrofarm Limited, Diavetra Lifesciences Private Limited and Hester Biosciences (Mauritius) Limited got merged with Company through a Scheme of Arrangement effective on 8 December 2015. Accordingly, the Company allotted and listed its 65 Equity Shares pursuant to Scheme of Arrangement vide order passed by Hon'ble High Court of Gujarat dated 8 December 2015 and the said Shares were listed at NSE Limited and BSE Limited in March, 2016. Leruarua Vetcare (Proprietary) Limited, incorporated in Botswana became an Associate Company with 49% stake of the Company and Innoves Animal Health Private Limited ceases to be an Associate Company due to transfer of shareholding of the Company in FY 2015-16. The Nepal unit completed trial operations and began commercial manufacturing in November, 2016. Leruarua Vetcare (Proprietary) Limited, Botswana ceases to be an Associate Company due to buyback of entire shareholding by the Associate Company during the FY 2016-17. The Company held 65% stake in subsidiary Company, Hester Biosciences Nepal Private Limited (HBNPL) and consequently, HBNPL became a subsidiary of Hester Biosciences Limited (Parent Company) during FY 2016-17. During the year 2017-18, Company acquired 54.80% in the capital of Texas Laboratories, a firm having a business place at Mehsana Distt. of Gujarat. In June 2017, Texas Laboratories converted into Private Limited Company namely, Texas Lifesciences Private Limited. Further, the Company incorporated 100% wholly-owned subsidiary, Hester Biosciences Africa Limited in Tanzania. During the year 2018-19, Hester Biosciences Limited incorporated 100% wholly-owned subsidiary Hester Biosciences Kenya Limited in Kenya.
Hester Biosciences schedules board meeting
Hester Biosciences will hold a meeting of the Board of Directors of the Company on 2 Augus...
Read more
25 Jul 202418:04
Hester Biosciences Ltd leads gainers in 'B' group
LGB Forge Ltd, Heubach Colorants India Ltd, Beekay Steel Industries Ltd and Pondy Oxides &...
Read more
21 Jun 202412:15
Board of Hester Biosciences recommends final dividend
Hester Biosciences announced that the Board of Directors of the Company at its meeting hel...
Read more
10 May 202416:16
Hester Biosciences to hold board meeting
Hester Biosciences will hold a meeting of the Board of Directors of the Company on 10 May ...
Read more
03 May 202410:30
Hester Biosciences to declare Quarterly Result
Hester Biosciences will hold a meeting of the Board of Directors of the Company on 2 Febru...
Read more
25 Jan 202411:28
Hester Biosciences to conduct board meeting
Hester Biosciences will hold a meeting of the Board of Directors of the Company on 7 Novem...
Read more
28 Oct 202317:23
FAQs for PE of Hester Biosciences Ltd
What is Hester Biosciences Ltd current share price?
What is Hester Biosciences Ltd's market cap?
What are Hester Biosciences Ltd's total net assets?
Is Hester Biosciences Ltd making a profit or loss?
Unlimited trading at just
Rs. 199